Mutations in the nonstructural region 5B of hepatitis C virus genotype 1b: Their relation to viral load, response to interferon, and the nonstructural region 5A

Journal of Medical Virology

Volumn 75, Issue 4, 2005, Pages 504-512

  Watanabe, Kazumasa ^a   Yoshioka, Kentaro ^b   Yano, Motoyoshi ^a   Ishigani, Masatoshi ^a   Ukai, Koji ^a   Ito, Hiroshi ^a   Miyata, Fumiyuki ^a   Mizutani, Tetsuya ^a   Goto, Hidemi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis C virus; Interferon therapy; Nonstructural 5B protein; Thumb domain

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; BETA INTERFERON; INTERFERON; NONSTRUCTURAL PROTEIN 5A; NS5B PROTEIN; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; PROTEIN DOMAIN; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

EID: 14344260444     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20301     Document Type: Article

References (55)

1. Ago H, Adachi T, Yoshida A, Yamamoto M, Habuka N, Yatsunami K, Miyano M. 1999. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure 7:1417-1426.
2. Alter MJ, Margolis HS, Krawezyski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA. 1992. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905.
3. Bartenschlager R. 1997. Molecular targets in inhibition of hepatitis C virus replication. Antiviral Chem Chemother 8:281-301.
4. Behrens SE, Tomei L, De Francesco R. 1996. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO 15:12-22.
5. Bressanelli S, Tomei L, Roussel A, Incitti I, Vitale RL, Mathieu M, Francesco R, Rey F. 1999. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci USA 96: 13034-13039.
6. Brown EA, Zhang H, Ping LH, Lemon SM. 1992. Secondary structure of the 5′-nontranslated regions of the hepatitis C and pestivirus genomic RNAs. Nucleic Acids Res 20:5041-5045.
7. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saito S, Suzuki Y, Murashima N, Ikeda K, Kumada H. 1997. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Heptology 25:745-749.
8. Chen PJ, Lin MH, Tai KF, Liu PC, Lin CJ, Chen DS. 1992, The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′-termini of viral genomic and antigenomic RNA. Virol 188:102-113.
9. Cheney IW, Naim S, Lai VC, Dempsey S, Bellows D, Walker MP, Shim J, Horscroft N, Hong Z, Zhong W. 2002. Mutations in NS5B polymerase of hepatitis C virus: Impacts or in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture. Virol 297:298-306.
10. Cho JM, Park YW, Lee YB, Yang JY, Kim CH, Choo SH, Ryu WS. 1995 Molecular cloning of hepatitis C virus genome from a single Korean blood donor. Mol Cells 5:317-324.
11. De Francesco R, Behrens SE, Tomei L, Altamura S, Jiricny J. 1996. RNA-dependent RNA polymerase of hepatitis C virus. Methods Enzymol 275:58-67.
12. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. 1994. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520.
13. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C, 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230.
14. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in nonstructural 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334:77-81.
15. Hayashi N, Higashi H, Kaminaka K, Sugimoto H, Esumi M, Komatsu K, Hayashi K, Sugitani M, Suzuki K, Tadao O. 1993, Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome. J Hepatol 17:94-107.
16. Hijikata M, Mizushima H, Tanji Y, Komada Y, Hirowatari Y, Akagi T, Kato N, Kimura K, Shimotohno K. 1993. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci USA 90:10773-10777.
17. Honda M, Kaneko S, Unoura M, Kobayashi K, Murakami S. 1992. Sequence comparisons for a hepatitis C virus genome RNA isolated from a patient with liver cirrhosis. Gene 120:317-318.
18. Honda M, Ping LH, Rijnbrand RC, Amphlett E, Clarke B, Rowlands D, Lemon SM. 1996. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virol 222:31-42.
19. Horiike N, Michitaka K, Masumoto T, Okura I, Akbar SF, Onji M. 1999. Relationship between the effect of interferon therapy and the change of hepatitis C virus non-structural 5B gene. J Gastroenterol Hepatol 14:345-351.
20. Joyce CM, Steitz TA. 1995. Polymerase structures and function: Variations on a theme? J Bact 77:6321-6329.
21. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 87:9524-9528.
22. Kiyosawa K, Sodeyama T, Tanaka F, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
23. Kolykhalov AA, Feinstonee SM, Rice CM. 1996. Identification of a highly conserved sequence element at the 3′-terminus of hepatitis C virus genome RNA. J Virol 70:3363-3371.
24. Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C. 1997. Analysis of genotypes and amino acid residues 2209-22 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 25:750-753.
25. Lesburg CA, Cable MB, Ferrari E, Hong Z, Mannarino AF, Weber PC. 1999. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol 6:937-943.
26. Lohmann V, Korner F, Herian U, Bartenschlager R. 1997. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol 71:8416-8428.
27. Lohmann V, Roos A, Korner F, Koch JO, Bartenschlager R. 1998. Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Virology 249:108-118.
28. Magg C, Castro C, Hong Z, Cameron CE. 2001. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as mediator of the antiviral activity of ribavirin. J Biol Chem 276:46094-46098.
29. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffmann M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C a randomized trial. Lancet 9286:958-965.
30. McKercher G, Beaulieu PL, Lamarre D, LaPlante S, Lefebvre S, Pellerii C, Thauvettte L, Kukolj G. 2004. Specific inhibitors of HCV polymerase identified using anNS5B with lower affinity for template/primer substrate. Nucleic Acids Res 22:422-431.
31. Nelson DR, Gray AH, Kolberg JA, LaPlante S, Lefebvre S, Pellerii C, Thauvettte L, Kukolj G. 1995. Variations of hepatitis C virus NS5B sequence (nucleotides 8,261-8,566) do not correlate with response to interferon-therapy. J Viral Hepatitis 2:285-292.
32. O'Reilly EK, Kao CC. 1998. Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure. Virol 252:287-303.
33. Oh JW, Ito T, Lai MCA. 1999. Recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol 73:7694-7702.
34. Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Peterson DA, Ito Y, Mishiro S. 1992a. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: Variability and stability. Virol 190:894-899.
35. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y. 1992b. Typing hepatitis C virus by polymerase chain reaction with specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679.
36. Poch O, Sauvaget I, Delarue M, Tordo N. 1989. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO 8:3867-3874.
37. Polyak SJ, McArdle S, Liu SL, Sullivan DG, Chung M, Hofgartner WF, Carithers RL, McMahon BJ, Mullins JI, Corey L, Gretch DR. 1998. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol 72:4288-4296.
38. Qin W, Yamashita T, Shirota Y, Lin Y, Wei W, Murakami S. 2001. Mutational analysis of the structure and function of hepatitis C virus RNA-dependent RNA polymerase. Hepatology 33:728-737.
39. Schalm SW, Weiland O, Hansen BE, Millella M, Lai MY, Hollander A, Michielsen PP, Bellobuono A, Chemello L, Pastore G, Chen DS, Brouwer JT. 1999. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials. Gastroenterology 117:408-413.
40. Sherlock S. 1995. Antiviral therapy for chronic hepatitis C viral infection. J Hepatol 23:3-7.
41. Simmonds P, McOnisch F, Yap PL, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS. 1993. Sequence variability in the 5′-non-coding region of hepatitis C virus: Identificaion of a new virus type and restriction on sequence diversity. J Gen Virol 74:661-668.
42. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
43. Squadrito G, Leone F, Sartori M, Nalpas B, Bertherot P, Raimondo G, Pol S, Brechot C. 1997. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alpha. Gastroenterology 113:567-572.
44. Sugiyama K, Kato N, Mizutani T, Ikeda M, Tanaka T, Shimotohno K. 1997. Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells. J Gen Virol 78:329-336.
45. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H. 1991. Structure and organization of hepatitis C virus genome isolated from human carriers. J Virol 65:1105-1113.
46. Tanaka T, Kato N, Nakagawa M, Ootsuyama Y, Cho MJ, Nakazawa T, Hijikata M, Ishimura Y, Shimotohno K. 1992. Molecular cloning of hepatitis C virus genome from a single Japanese carrier: Sequence variation within the same individual and among infected individuals. Virus Res 23:39-53.
47. Tanaka T, Kato N, Cho MJ, Shimotohno K. 1995. A novel sequence found at the 3′-terminus of hepatitis C virus genome. Biocheml Biophys Res Commun 215:744-749.
48. Tanaka T, Kato N, Cho MJ, Sugiyama K, Shimotohno K. 1996. Structure of the 3′-terminus of the hepatitis C virus genome. J Virol 70:3307-3312.
49. Tong MJ, El-Farra NS, Reikes AR, Co RL. 1995. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466.
50. Trowbridge R, Gowans EJ. 1998. Molecular cloning of an Australian isolate of hepatitis C virus. Arch Virol 43:501-511.
51. Wang Y, Okamoto H, Tsuda F, Nagayama R, Tao QM, Mishiro S. 1993. Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease. J Med Virol 40:254-260.
52. Yamada N, Tanihara K, Takada A, Yorihuzi T, Tsutsumi M, Shimomura I, Tsuji T, Date T. 1996. Genetic organization and diversity of the 3′-noncoding region of the hepatitis C virus. Virol 223:255-261.
53. Young KC, Lindsay KL, Lee KJ, Sullivan DG, Chung M, Hofgartner WT, Carithers RL, McMahon BJ, Mullins JI, Corey L, Gretch DR. 2003. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology 38: 807-810.
54. Zeuzem S, Lee JH, Roth WK. 1997. Mutations in the nonstrucuctural 5A gene of European hepatitis C virus isolates and response to interferon alpha. Hepatology 25:740-744.
55. Zeuzem S, Feinman SV, Rasennack L, Hathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ. 2000. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343:1666-1672.